Vertex, Inc.VERXEarnings & Financial Report
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
Revenue
$192.1M
Gross Profit
$121.3M
Operating Profit
$4.3M
Net Profit
$4.0M
Gross Margin
63.1%
Operating Margin
2.2%
Net Margin
2.1%
YoY Growth
12.7%
Vertex, Inc. Q3 FY2025 Financial Summary
Vertex, Inc. reported revenue of $192.1M (up 12.7% YoY) for Q3 FY2025, with a net profit of $4.0M (down 44.0% YoY) (2.1% margin). Cost of goods sold was $70.8M, operating expenses totaled $117.0M.
Key Financial Metrics
| Total Revenue | $192.1M |
|---|---|
| Net Profit | $4.0M |
| Gross Margin | 63.1% |
| Operating Margin | 2.2% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
Vertex, Inc. Q3 FY2025 revenue of $192.1M breaks down across 3 segments, led by Cloud Subscriptions at $92.0M (47.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Cloud Subscriptions | $92.0M | 47.9% |
| Software Licenses | $72.8M | 37.9% |
| Service Other | $27.3M | 14.2% |
Vertex, Inc. Revenue by Segment — Quarterly Trend
Vertex, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Cloud Subscriptions and Software Licenses) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Cloud Subscriptions | — | $94.6M | $92.0M | $86.2M |
| Software Licenses | — | $71.6M | $72.8M | $71.6M |
| Service Other | — | $28.5M | $27.3M | $26.7M |
Vertex, Inc. Annual Revenue by Year
Vertex, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $748.4M).
| Year | Annual Revenue |
|---|---|
| 2025 | $748.4M |
| 2024 | $666.8M |
| 2023 | $572.4M |
| 2022 | $491.6M |
Vertex, Inc. Quarterly Revenue & Net Profit History
Vertex, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $196.6M | +11.1% | $-2.5M | -1.3% |
| Q4 FY2025 | $194.7M | +9.1% | $-7.0M | -3.6% |
| Q3 FY2025 | $192.1M | +12.7% | $4.0M | 2.1% |
| Q2 FY2025 | $184.6M | +14.6% | $-961.0K | -0.5% |
| Q1 FY2025 | $177.1M | +12.9% | $11.1M | 6.3% |
| Q4 FY2024 | $178.5M | +15.2% | $-67.8M | -38.0% |
| Q3 FY2024 | $170.4M | +17.5% | $7.2M | 4.2% |
| Q2 FY2024 | $161.1M | +15.3% | $5.2M | 3.2% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $161.1M | $170.4M | $178.5M | $177.1M | $184.6M | $192.1M | $194.7M | $196.6M |
| YoY Growth | 15.3% | 17.5% | 15.2% | 12.9% | 14.6% | 12.7% | 9.1% | 11.1% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.02B | $1.19B | $1.17B | $1.15B | $1.20B | $1.22B | $1.27B | $1.21B |
| Liabilities | $790.7M | $931.8M | $987.4M | $953.7M | $950.1M | $957.4M | $1.01B | $967.9M |
| Equity | $233.1M | $259.0M | $179.4M | $200.5M | $248.0M | $264.5M | $258.9M | $246.5M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $57.7M | $41.4M | $41.1M | $14.8M | $46.0M | $62.5M | $42.3M | $38.0M |